Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

Mergers, Acquisitions & Collaborations in North America Sequencing Reagents Market 2028

Home - Blog - Mergers, Acquisitions & Collaborations in North America Sequencing Reagents Market 2028

Table of Contents

The North America sequencing reagents market is expected to reach US$ 5,464.95 million by 2028 from US$ 2,353.66 million in 2021; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028.

Get a sample PDF of the report – https://www.businessmarketinsights.com/sample/TIPRE00022812?utm_source=Blog&utm_medium=10640 

Sequencing reagents are essential components of sequencing reactions, enabling applications ranging from research to clinical diagnostics. Their market growth is primarily driven by increased research funding, declining sequencing costs, and expanding clinical adoption—though a shortage of skilled professionals poses a challenge.

Genomic sequencing is rapidly integrating into clinical practice. Over the next five years, healthcare systems are projected to generate genomic data for over 60 million patients, supported by substantial government investment exceeding US$4 billion across 14+ countries. These national genomic-medicine initiatives accelerate real-world implementation while addressing barriers to adoption, thereby boosting demand for sequencing reagents.

Additional growth drivers include:

  1. Sustained Funding: Continuous investment by governments and manufacturers in genomics research.

  2. Cost Reduction: Significant declines in next-generation sequencing (NGS) prices due to technological advancements and methodological improvements.

The COVID-19 pandemic further highlighted the value of sequencing. In North America, particularly the US, genomic sequencing became critical for tracking SARS-CoV-2 variants and guiding public health responses. This urgency enhanced sequencing capacity and collaboration, strengthening the regional market despite initial healthcare burdens.

Collectively, these factors—clinical integration, robust funding, lower costs, and pandemic-driven demand—position the sequencing reagents market for significant expansion.

NORTH AMERICA SEQUENCING REAGENTS MARKET SEGMENTATION

By Technology

  • Next Generation Sequencing
  • Sanger Sequencing
  • Third Generation Sequencing

By Reagent Type

  • Control Kits
  • Library Kits
  • Template Kits
  • Sequencing Kits
  • Other Reagent Types

By Application

  • Agri genomics and Forensics
  • Clinical Investigation
  • Oncology
  • Reproductive Health
  • Other Applications

By End User   

  • Hospitals and Clinics
  • Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • Pacific Biosciences of California, Inc.
  • QIAGEN
  • Takara Bio Inc.
  • THERMO FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC Biosearch Technologies

North America Sequencing Reagents Strategic Insights

Strategic insights for the North America Sequencing Reagents provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Sequencing Reagents Regional Insights

The geographic scope of the North America Sequencing Reagents refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights